JNJ Stock Analysis | Johnson & Johnson RSI, Financials, Earnings & Insider Data

Moving averages

SMA 50$265.55+2.88%

SMA 200$242.92+12.47%

EMA 20$264.57+3.26%

Company profile

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

SectorHealthcare

IndustryDrug Manufacturers - General

Market cap$630.04B

P/E ratio30.29

EPS$8.63

Beta0.206

Dividend yield2.04%

52-week high$281.07

52-week low$180.57

Insider transactions

Executive	Title	Action	Shares	Date
PINTO, DANIEL E	Director	Buy	113	2026-09-08
HEWSON, MARILLYN A	Director	Buy	180	2026-09-08
WOODS, EUGENE A.	Director	Buy	135	2026-09-08

Continue with Google

Sign in: free for 30 days

Latest news

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.

Somewhat-Bullish The Globe and Mail 13 hours ago

Intuitive Surgical Stock Just Fell Despite a 22% Revenue Jump. Here's What Investors Are Missing.

Somewhat-Bullish The Globe and Mail 13 hours ago

Realty Income (O) Stock Price, News & Analysis

Neutral 24/7 Wall St. 2 days ago

Earnings call transcript

Q2 2026

Good morning. Welcome to Johnson & Johnson's second quarter 2026 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being recorded. If anyone has any objections, you may disconnect at this time. If you experience technical difficulties during the conference, you may press star zero to reach the operator. I will now turn the conference call over to Ryan Kurz from Johnson & Johnson. You may begin.…

Continue with Google

Sign in: free for 30 days

Options chain

Type	Strike	Expiry	Volume	Open interest
Call	$275.00	2026-10-30	1,386	552
Call	$275.00	2026-11-20	1,050	210
Call	$280.00	2026-11-20	870	2,951

Continue with Google

Sign in: free for 30 days

ETFs holding JNJ

VIG 2.83% of the fund RSI 68 JEPI 1.75% of the fund RSI 61

Similar stocks in Drug Manufacturers - General

PFE Pfizer Inc RSI 67 LLY Lilly(Eli) & Company RSI 78 BMY Bristol-Myers Squibb Company RSI 55 MRK Merck & Co Inc RSI 57 ABBV Abbvie Inc RSI 73 AMGN AMGEN Inc RSI 71 GILD Gilead Sciences Inc RSI 74 NVO Novo Nordisk RSI 54 GSK GSK Plc RSI 51 OGN Organon & Company RSI 68

30 days of PRO Unlimited free, no card

RSI alerts for JNJ

An email when JNJ closes below RSI 30 or above 70. Nothing else.

Add alert